Document is current
Any future updates will be listed below
-
Authors
Davis, Andrew A.
Hesse, Jennifer
Pereira, Patrícia M. R.
Ma, Cynthia X.
-
Funding
Funding for this research was provided by:
Breast Cancer Alliance
- License Information
-
More Information
Article History
Received: 30 December 2024
Accepted: 10 March 2025
First Online: 13 May 2025
Competing interests
: Davis A.A. reports receiving a grant from the Breast Cancer Alliance, travel expenses from DAVA Oncology, and participation in scientific advisory boards with Pfizer and Biotheranostics. Ma C.X. reports receiving funding from Pfizer and consulting fees from Eli Lilly, Pfizer, Stemline, AstraZeneca, Danatlas, Regor Therapeutics, Merck, Novartis, Daiichi, and Olaris. The other authors declare no conflicts of interest.
